Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
FOCAD - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
LOC90784 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LRRN2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IVD - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM210B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
POMT2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
POLR3H - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RILPL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLIRP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NCBP3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NDUFA8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
NHS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MMAB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C1orf162 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
INPP4B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC11A1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MAP3K13 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on